for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Evolent Health Inc

EVH.N

Latest Trade

8.43USD

Change

0.17(+2.06%)

Volume

76,713

Today's Range

8.25

 - 

8.59

52 Week Range

5.50

 - 

22.02

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
8.26
Open
8.32
Volume
76,713
3M AVG Volume
33.28
Today's High
8.59
Today's Low
8.25
52 Week High
22.02
52 Week Low
5.50
Shares Out (MIL)
84.61
Market Cap (MIL)
760.65
Forward P/E
-12.91
Dividend (Yield %)
--

Latest Developments

More

Evolent Health Reports Third Quarter Results

Evolent Health Reports Q2 2019 Results

Evolent Health Expands Partnership With Passport Health Plan

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Evolent Health Inc

Evolent Health, Inc. is engaged in healthcare delivery and payment. The Company supports health systems and physician organizations in their migration toward value-based care and population health management. The Company provides an end-to-end, technology-enabled services platform for providers. The Company's platform, powered by its technology, processes and integrated services, enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to payment models that reward value-based payment models. The Company's services include providing its customers, with a population management platform, integrated data and analytics capabilities, pharmacy benefit management (PBM) services and comprehensive health plan administration services. Its value-based operations are empowered and supported by Identifi. Identifi is the Company's technology platform that aggregates and analyzes data, manages care workflows and engages patients.

Industry

Healthcare Facilities

Contact Info

800 N Glebe Rd Ste 500

+1.571.3896000

https://www.evolenthealth.com/

Executive Leadership

Frank John Williams

Chairman of the Board, Chief Executive Officer

Seth Blackley

President, Co-Founder, Director

John Paul Johnson

Chief Financial Officer

Thomas Peterson

Chief Operating Officer

Nicholas P. McGrane

Executive Vice President of Corporate Performance

Key Stats

1.75 mean rating - 12 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.3K

2017

0.4K

2018

0.6K

2019(E)

0.8K
EPS (USD)

2016

-0.570

2017

-0.350

2018

-0.120

2019(E)

-0.696
Price To Earnings (TTM)
--
Price To Sales (TTM)
0.95
Price To Book (MRQ)
0.69
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
20.57
LT Debt To Equity (MRQ)
20.57
Return on Investment (TTM)
-9.51
Return on Equity (TTM)
-8.18

Latest News

Latest News

BRIEF-Evolent Health Reports Qtrly Loss Per Share $0.18

* Q1 REVENUE $139.7 MILLION VERSUS I/B/E/S VIEW $140.7 MILLION

BRIEF-Unitedhealth Group Says Advisory Board Co Sold 3 Million Shares Of Class A Common Stock Of Evolent Health In Private Sale At $13.70 Per Share

* UNITEDHEALTH GROUP SAYS ON MARCH 1, ADVISORY BOARD CO SOLD 3 MILLION SHARES OF CLASS A COMMON STOCK OF EVOLENT HEALTH IN PRIVATE SALE AT $13.70 PER SHARE

BRIEF-Evolent Health Reports Qtrly ‍loss Per Share $0.18​

* EVOLENT HEALTH ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 RESULTS

BRIEF-Evolent Health Sees Adjusted Services Revenue Growth In Mid-To-High Teens For 2018

* EVOLENT HEALTH SAYS ANTICIPATES MEETING OR EXCEEDING ISSUED ADJUSTED REVENUE, ADJUSTED EBITDA GUIDANCE FOR THREE MONTHS ENDED DEC 31, 2017 - SEC FILING

BRIEF-Evolent Health And Premier Health Terminate Agreement For Acquisition Of Premier Health Plan

* EVOLENT HEALTH AND PREMIER HEALTH ANNOUNCE TERMINATION OF AGREEMENT FOR ACQUISITION OF PREMIER HEALTH PLAN

BRIEF-Evolent Health announces third quarter 2017 results

* Q3 revenue $107.9 million versus I/B/E/S view $104.5 million

BRIEF-Evolent Health ‍signed expanded relationship agreement with Premier Health​

* Evolent Health Inc - signed an expanded relationship agreement with long-standing customer, Premier Health

BRIEF-Jpmorgan Chase & Co reports 10 pct passive stake in Evolent Health Inc as of Sept. 29

* Jpmorgan chase & co reports 10 percent passive stake in Evolent Health Inc as of September 29, 2017 - SEC filing Source text for Eikon: Further company coverage:

BRIEF-Evolent Health announces proposed expansion of relationships in Illinois and New Mexico

* Evolent Health announces proposed expansion of relationships in Illinois and New Mexico

BRIEF-Evolent health prices public offering of 8.8 mln class A shares at $19.85 per share

* Evolent Health announces pricing of public offering of class a common stock

BRIEF-Evolent Health files for potential stock shelf size not disclosed - SEC filing

* Files for potential stock shelf; size not disclosed - SEC filing

BRIEF-Evolent Health Inc says launch of a proposed public offering of $175 mln of its class A common stock

* Evolent Health Inc announces proposed public offering of class A common stock

BRIEF-Evolent Health Q2 loss per share $‍0.28​

* Q2 revenue $107.1 million versus I/B/E/S view $104.5 million

BRIEF-Evolent Health launches secondary public offering of class A common stock

* Evolent Health Inc announces launch of secondary public offering of class A common stock

BRIEF-Evolent Health announces pricing of secondary offering of class A stock

* Evolent Health, Inc announces pricing of secondary public offering of class A common stock

BRIEF-Evolent Health announces launch of secondary public offering of class A common stock

* Evolent Health, Inc announces launch of secondary public offering of class a common stock

Exclusive - Evolent Health explores merger with Advisory Board: sources

Healthcare technology provider Evolent Health Inc <EVH.N> is exploring a potential combination with Advisory Board Co <ABCO.O>, the business consulting company targeted by activist fund Elliott Management, people familiar with the matter said.

BRIEF-Pennant Capital Management reports 5.25 percent passive stake in Evolent Health as of December 31, 2016

* Pennant Capital Management LLC reports a 5.25 percent passive stake in Evolent Health Inc as of December 31, 2016 -SEC filing Source text : [ID:http://bit.ly/2lH0OgD] Further company coverage:

BRIEF-Evolent Health says announces proposed offering of $110 mln of convertible senior notes due 2021

* Evolent health, inc. Announces proposed offering of $110 million of convertible senior notes due 2021

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up